James Solomon
Dermatology · North Las Vegas, NVNPI 1023128345
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (30.3%), speaking fees and food and beverage — rather than concentrated in one kind of arrangement. 22 manufacturers reported payments, led by LEO Pharma AS at 30.3% of the total. Reporting peaked in 2019 at $6,362 and has fallen 98.0% since, to $125 in 2025.
Across 89 payments — averaging $160.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- LEO Pharma AS$4K
- Sun Pharmaceutical Industries Inc.$4K
- Pfizer$4K
- AbbVie$364
- E.r. Squibb & Sons, L.L.C.$353
- Genentech USA, Inc.$236
- plus $1K from 16 others
Across 226 payments — averaging $3177.96 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Incyte Corporation$195K
- AbbVie$171K
- Pfizer$138K
- UCB SA$110K
- Taro Pharmaceuticals USA, Inc.$74K
- E.r. Squibb & Sons, L.L.C.$15K
- plus $16K from 4 others
What the payments were for
- Consulting fees$4,33430%
- Speaking & faculty fees$4,14929%
- Travel & lodging$2,40317%
- Food & beverage$3,39224%
- Education$150%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| LEO Pharma AS | 2 | $4,334 |
| Sun Pharmaceutical Industries Inc. | 5 | $4,214 |
| Pfizer | 15 | $3,540 |
| AbbVie(2 entities) | 9 | $364 |
| E.r. Squibb & Sons, L.L.C. | 7 | $353 |
| Genentech USA, Inc. | 9 | $236 |
| Novartis | 15 | $231 |
| Incyte Corporation | 3 | $209 |
| Sanofi | 3 | $174 |
| UCB, Inc. | 3 | $146 |
| Dermavant Sciences, Inc. | 1 | $140 |
| Bristol Myers Squibb | 3 | $62 |
| Amgen | 3 | $59 |
| Mayne Pharma Commercial LLC | 1 | $59 |
| Galderma Laboratories, L.p. | 2 | $34 |
| Regeneron Healthcare Solutions, Inc. | 1 | $30 |
| Strata Skin Sciences, Inc. | 2 | $23 |
| Sanofi-aventis U.S. LLC | 1 | $21 |
| Lilly USA, LLC | 1 | $18 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $18 |
| Johnson & Johnson | 1 | $14 |
| Mylan Pharmaceuticals Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ODOMZO$4,149
- VTAMA$140
- DUPIXENT$125
- BOTOX COSMETIC$123
- Erivedge$116
How this compares
$14,293 in reported general payments places this provider in the 80th percentile of 78 dermatology providers in Nevada.
Other dermatology in North Las Vegas
- Lawrence AbramsonNorth Las Vegas$2K
- David CotterLas Vegas$1.4M
- Harry GreenbergLas Vegas$1.1M
- Miriam BettencourtLas Vegas$772K
- Victoria FarleyLas Vegas$151K
- Curt SamlaskaHenderson$101K
- Laura OstezanReno$27K
- Robert LiebermanHenderson$22K
- Linda WoodsonLas Vegas$22K
- Candace SpannLas Vegas$18K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.